Key facts
- This page summarizes Brian L. Durkin's Form 4 filing for AbbVie Inc. (ABBV).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Mar 2023, 16:03.
Brian L. Durkin - 28 Feb 2023 Form 4 Insider Report for AbbVie Inc. (ABBV)
- Reporting relationship
- VP, CONTROLLER
- Issuer ticker
- ABBV
- Reported as of
- 28 Feb 2023
- Net transaction value
- -$1,725,159
- SEC form
- 4
- Accepted by SEC
- 02 Mar 2023, 16:03:43 UTC
- Prior SEC filing
- 21 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- Steven Scrogham, attorney-in-fact for Brian L. Durkin
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Brian L. Durkin filed Form 4 for AbbVie Inc. (ABBV) on 02 Mar 2023.
Change
- Previous filing in this sequence was filed on 21 Feb 2023.
- Current net transaction value: -$1,725,159.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ABBV
transaction
Common Stock, $0.01 par value
Tax liability
- Transaction value
- $1,725,159
- Shares
- -11,182
- Change %
- -25%
- Price
- $154.28
- Shares after
- 33,149
- Date
- 28 Feb 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.